Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bafna Pharmaceuticals Ltd has scheduled a Board meeting on May 29, 2026 to consider and approve the Audited Financial Results for Q4 and the full year ended March 31, 2026. The company has also confirmed that its trading window remains closed from April 1, 2026 to May 31, 2026 for designated persons and their immediate relatives, in line with its Insider Trading Prevention Code. This is a routine pre-result announcement intimation filed under SEBI regulations. No specific financial data or developments are disclosed in this filing.
This is a standard procedural filing ahead of the annual earnings announcement. The actual financial results will be disclosed after the May 29 board meeting, which will be the more significant event for investors. The trading window closure confirms insider trading safeguards are in place.